Dr Gerard Smith, DMD | |
343 Commercial Dr, Suite B, Savannah, GA 31406-3606 | |
(912) 356-3636 | |
Not Available |
Full Name | Dr Gerard Smith |
---|---|
Gender | Male |
Speciality | Dentist - Endodontics |
Location | 343 Commercial Dr, Savannah, Georgia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063515989 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223E0200X | Dentist - Endodontics | 8917 (Georgia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Gerard Smith, DMD 343 Commercial Dr, Suite B, Savannah, GA 31406-3606 Ph: () - | Dr Gerard Smith, DMD 343 Commercial Dr, Suite B, Savannah, GA 31406-3606 Ph: (912) 356-3636 |
News Archive
Mary Ann Liebert, Inc. announces the launch of its new website, offering streamlined access to over 92,000 articles from 70 high-impact publications. Using the latest technology, LiebertPub.com introduces an intuitive interface that helps users discover content quickly and easily, as well as new tools to help librarians manage access.
Diabetes is a major cause of heart disease and stroke, and the leading cause of kidney failure. It's a condition that impacts nearly 26 million people in the U.S., or 8.3 percent of the population, and, if current trends continue, as many as 1 in 3 U.S. adults could have diabetes by 2050.1 That's why Alere Health, LLC, and AT&T are teaming up to provide patients with a better way to manage and control their diabetes.
SCLogic, a leading provider of mobile enterprise package tracking software systems, today announced the donation of its SCLIntra(TM) package tracking system to Give Kids The World. The system includes a donation of a Motorola MC55 Enterprise Digital Assistant (EDA).
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced the initiation of a confirmatory Phase 3 clinical trial to further evaluate otelixizumab in autoimmune new-onset type 1 diabetes. The confirmatory Phase 3 clinical trial is called DEFEND-2 (Durable-Response Therapy Evaluation For Early or New-Onset Type 1 Diabetes) and immediately follows successful completion of enrollment in the initial Phase 3 clinical trial, DEFEND-1, with results from DEFEND-1 expected in the first half of 2011.
› Verified 9 days ago
Dr. Mark W Dusek, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 500 Eisenhower Dr, Savannah, GA 31406 Phone: 912-355-7022 Fax: 912-355-1415 | |
Dr. Felix T Maher, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 5302 Frederick St, Suite 101, Savannah, GA 31405 Phone: 912-352-0546 Fax: 912-352-9386 | |
Dr. Christian Rosario Patti, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 5509 Paulsen St, Savannah, GA 31405 Phone: 912-354-9204 Fax: 912-420-5020 | |
Dr. William Stephen Ray Jr., D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 5509 Paulsen St, Savannah, GA 31405 Phone: 912-354-9204 Fax: 888-682-5153 | |
Donihue Waters, DDS MDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 9100 White Bluff Rd, Suite 104, Savannah, GA 31406 Phone: 912-354-3474 Fax: 912-354-7438 | |
Dr. Robert Alexander Bosque Jr., DMD Dentist Medicare: Medicare Enrolled Practice Location: 723 E 65th St, Savannah, GA 31405 Phone: 912-355-0555 Fax: 912-353-9042 | |
Grant Zakhar, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2127 E Victory Dr, Savannah, GA 31404 Phone: 855-901-6831 |